Measuring stomach emptying in healthy people and semaglutide users
Part of Hormones & metabolism clinical trials.
This study looks at how quickly food leaves the stomach in healthy people and in those taking semaglutide. It aims to see if semaglutide changes stomach emptying, which could help doctors understand and manage digestive side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be a generally healthy person or someone who currently takes semaglutide (a medication for diabetes or weight loss).
- You cannot have had weight-loss (bariatric) surgery in the past.
- You cannot have a hiatal hernia (a condition where the stomach pushes through the diaphragm).
- You must be able to understand and sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a high dose of semaglutide (a medicine used for weight management) to see how it affects stomach emptying in people with excess weight. Participating may help understand how this treatment works and could lead to better options for weight loss.
This study looks at whether nerve damage from diabetes affects how long semaglutide (a diabetes medicine) stays in the stomach, which can cause stomach retention. It may help doctors understand who is more likely to have this side effect.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.
This study looks at whether stopping semaglutide for one week before a sedated endoscopy improves how well the stomach is seen and how quickly it empties. It may help doctors better understand how this medicine affects the procedure.
Hear when a new Diabetes Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.